Informations:
Erreur:
ID
12026
Description
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes; ODM derived from: https://clinicaltrials.gov/show/NCT01950468 Principal Investigator: Stephen Flitman, M.D and Ira Goodman, M.D
Lien
https://clinicaltrials.gov/show/NCT01950468
Mots-clés
Versions (1)
- 01/09/2015 01/09/2015 -
Téléchargé le
1 septembre 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Parkinson's Syndrome NCT01950468
Eligibility Parkinson's Syndrome NCT01950468
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson's Syndrome NCT01950468
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
informed consent
Item
Subject has provided written informed consent before the initiation of any study related procedures and continues to give willing consent for participation
boolean
C0021430 (UMLS CUI [1])
age
Item
Age ≥ 40 years
boolean
C0001779 (UMLS CUI [1])
EXTREMITY TREMOR, UPPER
Item
Have had upper extremity tremor for < 3 years duration, regardless of presumed diagnosis or etiology
boolean
C0239412 (UMLS CUI [1])
UPDRS score
Item
Have a UPDRS part III score upon entry of ≤ 16
boolean
C3827698 (UMLS CUI [1])
physical;psychological disease
Item
Any clinically significant or unstable physical or psychological illness based on medical history or physical examination at screening, as determined by the investigator
boolean
C0205485 (UMLS CUI [1])
C1658764 (UMLS CUI [2])
C1658764 (UMLS CUI [2])
Brain Diseases
Item
Structural brain abnormality affecting the entire brain (e.g., normal pressure hydrocephalus) or the striatum (e.g., local tumor or stroke)
boolean
C0006111 (UMLS CUI [1])
laboratory results;Abnormal
Item
Any clinically significant abnormal laboratory results obtained at screening and as determined by the investigator
boolean
C1254595 (UMLS CUI [1])
C0205161 (UMLS CUI [2])
C0205161 (UMLS CUI [2])
electrocardiogram results; abnormal
Item
Any clinically significant abnormal electrocardiogram (ECG) results obtained at screening and as determined by the investigator
boolean
C2826714 (UMLS CUI [1])
C0205161 (UMLS CUI [2])
C0205161 (UMLS CUI [2])
drug abuse
Item
Any history of drug, narcotic, or alcohol abuse within 2 years before the date of informed consent, as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association, Fourth Edition, revised (DSM-IV-TR [American Psychiatric Association, 1994])
boolean
C0013146 (UMLS CUI [1])
Urine drug screen positive
Item
Positive urine drug screen for opiates, cocaine, or amphetamines at screening
boolean
C0743300 (UMLS CUI [1])
positive pregnancy test
Item
Positive pregnancy test before imaging
boolean
C0240802 (UMLS CUI [1])
Participation; Clinical Trials
Item
Participation in an investigational drug or device clinical trial within 30 days before the date of informed consent
boolean
C0679823 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C0008976 (UMLS CUI [2])
Imaging Agent
Item
Previous scan with any DAT imaging agent (e.g. [123I]NAV5001, Altropane, DaTscan, DOPASCAN)
boolean
C1512628 (UMLS CUI [1])
radiopharmaceuticals
Item
Any exposure to radiopharmaceuticals within 30 days before the date of informed consent
boolean
C0182638 (UMLS CUI [1])
Breast-feeding
Item
Breast-feeding
boolean
C0006147 (UMLS CUI [1])
Supine Position
Item
Inability to lie supine for 1 hour
boolean
C0038846 (UMLS CUI [1])
thyroid disease;
Item
Any thyroid disease other than adequately treated hypothyroidism
boolean
C0040128 (UMLS CUI [1])
Iodine allergy; Iodine compounds allergy
Item
Known sensitivity or allergy to iodine or iodine containing products
boolean
C0571818 (UMLS CUI [1])
C0571817 (UMLS CUI [2])
C0571817 (UMLS CUI [2])
dopamine receptor binding;Pharmacologic Substance
Item
Treatment within the 30 days before the date of imaging with amoxapine, amphetamine, benztropine, bupropion, buspirone, cocaine, mazindol, methamphetamine, methylphenidate, norephedrine, phentermine, phenylpropanolamine, selegiline, and sertraline, paroxetine, or citalopram.
boolean
C1323365 (UMLS CUI [1])
C1254351 (UMLS CUI [2])
C1254351 (UMLS CUI [2])